We require your email address in order to send you alerts by email. You can unsubscribe at any time.

You can choose which alerts you receive and can unsubscribe at any time.

Unlock ADVANCED ONCOTHERAPY PLC's Credit Report?

Buy This Report

  • 12 months access to this report
  • Free email alerts for key changes
  • Includes 5 Companies House documents
  • Personal dashboard to track and monitor companies at a glance
  • Company scores, financials, risk indicators, CCJ's & payment data
  • Directors, shareholders & ownership details
Buy Now - £20.00
UNLIMITED ACCESS

Get Unlimited Reports For

£35/month

Cancel Anytime

SAVE 15%

Get Unlimited Reports For

£350/year

Cancel Anytime

Upgrade to Lite

  • 5 credit reports
  • 100 accounts downloads
  • 100 accounts exports

Your plan will start immediately and the time remaining on your existing plan will be refunded

Yes, upgrade to Lite
Credit report booklet

Lock icon Unlock the Full Company Report

  • Check whether this company is legitimate
  • See if this company is likely to run into financial trouble
  • Find out who owns and runs the company
  • Avoid risky business relationships
  • Get instant updates if anything important changes
  • Access official company documents for free

ADVANCED ONCOTHERAPY PLC

Public limited with Share Capital

In Administration

15 September 2005

86900 Other human health activities - Other human health activities

Available to 30 Jun 2022. Next accounts due by 30 Sep 2023

Is ADVANCED ONCOTHERAPY PLC in debt to you?

Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.

Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.

We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.

Remove These Ads

Current Directors & Secretaries

For a full in-depth analysis on each of these directors, click any of the links below

Name Role Date Of Birth Appointed
Ms Lori Jo Cross Director
Mrs Renhua Zhang Director
Chunlin Han Director
Dr Piers Nicholas Plowman Director
Professor Stephen Myers Director
Mr Hans Henrik Von Celsing Director
Mr Nicolas Serandour Director
Mr Enrico Vanni Director
Mr Michael Stephen Bradfield Director
Dr Michael Jeffrey Sinclair Director

Previous Directors & Secretaries

Remove These Ads

Mortgages and Charges

Total Outstanding

15

Total Satisfied

4

Type Created Registered Persons Entitled Status
Glas Trust Corporation Limited As Security Agent And Trustee For The Secured Parties (As Define OUTSTANDING
Glas Trust Corporation Limited As Security Trustee For The Secured Parties (As Defined In The I OUTSTANDING
Glas Trust Corporation Limited As Security Agent And Trustee For The Secured Parties (As Define OUTSTANDING
Nerano Pharma Limited OUTSTANDING
Nerano Pharma Limited OUTSTANDING
Nerano Pharma Limited OUTSTANDING
Nerano Pharma Ltd OUTSTANDING
Nerano Pharma Ltd OUTSTANDING
Nerano Pharma Ltd OUTSTANDING
Nerano Pharma Limited OUTSTANDING
Nerano Pharma Ltd OUTSTANDING
Nerano Pharma Limited OUTSTANDING
Nerano Pharma Limited OUTSTANDING
Nerano Pharma Limited OUTSTANDING
Nerano Pharma Limited SATISFIED
Credit Suisse Ag OUTSTANDING
Henslow Trading Limited SATISFIED
Debenture Charles Street Securities Europe Llp As Security Trustee SATISFIED
Rent And Service Charge Deposit Deed Lazari Investments Limited SATISFIED
Remove These Ads
Accounts
Cash £4,260,491.00 £2,317,451.00 £3,235,167.00 £1,013,053.00 £56,478.00
Net Worth -£7,207,942.00 -£12,727,137.00 -£6,248,364.00 -£6,169,575.00 -£1,908,122.00
Total Current Liabilities £16,117,981.00 £17,885,386.00 £6,475,901.00 £8,954,777.00 £16,738,508.00
Total Current Assets £30,730,475.00 £26,340,998.00 £22,192,643.00 £13,677,598.00 £12,500,562.00
Remove These Ads

Frequently Asked Questions about ADVANCED ONCOTHERAPY PLC

Detailed answers about ADVANCED ONCOTHERAPY PLC, including incorporation, status, business activity, and accounts information.

When was ADVANCED ONCOTHERAPY PLC founded?

ADVANCED ONCOTHERAPY PLC was officially incorporated on 15 September 2005 and is registered under company number 05564418. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.

What type of company is ADVANCED ONCOTHERAPY PLC?

Public limited with Share Capital. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.

What is the current status of ADVANCED ONCOTHERAPY PLC?

ADVANCED ONCOTHERAPY PLC's current status is Pending. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.

What does ADVANCED ONCOTHERAPY PLC do?

ADVANCED ONCOTHERAPY PLC operates in the following sector: 86900 Other human health activities - Other human health activities . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.

What is ADVANCED ONCOTHERAPY PLC's registered address?

The registered office address of ADVANCED ONCOTHERAPY PLC is 110, Cannon Street, London, City Of London, EC4N 6EU. This is the official address filed with Companies House for legal and statutory correspondence.

Is ADVANCED ONCOTHERAPY PLC financially stable?

Based on the latest accounts up to 30 Jun 2022, ADVANCED ONCOTHERAPY PLC has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 30 Sep 2023. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.